SOCS2 is thought to be negatively associated with enhanced TG secretion from the liver and insulin resistance (Zadjali et al., 2012), while CPT1 plays an important role in enhancing fatty acid oxidation. The gene discussed is CPT1A; the disease is Insulin resistance.